Question 1

What is Travere Therapeutics Inc (TVTX) stock price today?

Accepted Answer

Travere Therapeutics Inc (TVTX) currently trades at $40.10 per share. The stock has a market capitalization of $3.70B and a P/E ratio of —x.

Question 2

Is TVTX stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Travere Therapeutics Inc has a Smart Value Score of 32/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Travere Therapeutics Inc's revenue and earnings?

Accepted Answer

Travere Therapeutics Inc has trailing twelve-month (TTM) revenue of $490.73M with profit margins of -5.21%. Earnings per share (EPS) is $-0.57.

Question 4

Is TVTX stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Travere Therapeutics Inc's intrinsic value is $61.58, representing a margin of safety of 50.93%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$109.46M	$145.24M	$233.18M	$490.73M	$490.73M
Net income	$-278.48M	$-111.40M	$-321.55M	$-50.26M	$-21.99M
EPS	—	—	—	—	$-0.57
Free cash flow	$-214.66M	$-321.61M	$-338.69M	$-20.37M	$60.30M
Profit margin	-254.41%	-76.70%	-137.90%	-10.24%	-5.21%

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TVTX	$3.70B	32	8.0	2.0	6.7	5.0	+50.93%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Travere Therapeutics Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare